High through screening(HTS)를 이용한 白鼠의 脾臟細胞에서의 IL-5 분비 조절 韓藥物 Screening
Interleukin-5 Inhibition Assay of the Oriental Materia Medica Treatment by High Through Screening on the Splenocyte of Mouse
0
조회
0
다운로드
2
인용
0
참고문헌
초록
Abstract
Backgrounds and Objectives: Asthma is considered to be an inflammatory disease characterized by airway hyperresponsiveness and pulmonary eosinophilia. And it is known the structure and function of IL-5, its receptor and the mechnism IL-5 triggered eosinophil accumulation and inflammaion of the airways. At this point of view, we assume which oriental materia medica can the splenocyte inhibit from secreting the IL-5 in vitro. Material and Methods: We used the splenocyte of mouse 8 weeks after its birth, and then cultivated those into the 2 experimental groups and control group for 48 hours. The culture medium of experimental groups were made of 1㎍/㎖, 10㎍/㎖oriental materia medica, representative. And the culture media of control group was given no oriental materia medica. Then, we assayed the quantity of cytokine-expression by the Sandwich ELISA. The quantities of cytokine-expression of the experimental groups were compared with that of the control group which was standardized. These method were used for the all of oriental materia medica treated. Results: In this study, we demonstrated that 12 oriental materia medica that inhibit the splenocyte from secreting the IL-5 in both 1㎍/㎖ and 10㎍/㎖ culture media. Those were Equiseti Herba, Sophorae Subprostratae Radix, Moutan Radicis Cortex, Trichosanthis Radix, Buddleiae Flos, Cyperi Rhizoma, Benincasae Semen, Armeniacae Semen, Zedoariae Rhizoma, Astragali Semen, Dolichoris Semen, Lilii Bulbus, Asparagi Radix, Atractylodes Rhizoma White, Polygonati Officinallis Rhizoma. Conculusions: These findings indicate that some oriental materia medica, specially Antipyretics, Herbs for Resolving Phlegm, Relieving Cough and Calming Wheezing and Herbs for Tonifying and Invigorating effects inhibit the splenocyte from secreting the IL-5. And further study experimented in vivo is needed for treating IL-5-driven inflammatory disease including asthma.
참고문헌 (25)
- "Effects of an Interleukin5 blocking monoclonal antibody on eosinophils airway hyper responsiveness and the late asthmatic response", 356 (2000)
- "Allergy principles & practice", pp.838~858 (1998), Mosby
- "천식과 알레르기", pp.237~256 (2002), 군자출판사
- "The role of eosinophils and neutrophils in inflammation", 3(1), pp.22~27 (2002)
- "천식과 호산구", 16(1), pp.8~14 (1996)
- "Cytokines as mediators of chronic asthma", 150 (1994)
- "금은화가 천식유발 cytokine 분비와 호산구 chemotaxis에 미치는 영향", 26(1), pp.129~42 (2005)
- "목단피가 천식유발 cytokine 분비와 호산구 chemotaxis에 미치는 영향", 26(1), pp.199~212 (2005)
- "알레르기 질환의 치료로서 CpG DNA", 48(3), pp.251~259 (2005)
- "differnet patterns of lymphokine secretion lead to different functional properties", pp.145~73
- "Asthma and allergy disorders of civilization?", 91, pp.171~184 (1998)
- "Allergy", pp.26~ (2004), Mosby
- "임상호흡기학", pp.208~ (2002), 일조각
- "東醫肺系內科學", pp.192~193 (2004), 도서출판 국진
- "천식과 알레르기", pp.237~256 (2002), 군자출판사
- "Staphylococcal enterotoxin induced IL5 stimulation as a cofactor in the pathogenesis of atopic disease the hygiene hypothesis in reverse?", 58(3), pp.252~256 (2003)
- "IL5 and IL5 receptor in asthm", 92(2), pp.75~91 (1997)
- "Role of interleukin5 and eosinophils in allergen induced airway remodeling in mice", 31(1), pp.62~68 (2004)
- "Role of IL5 in the development of allergen induced airway hyperresponsiveness", 120(1), pp.8~16 (1999)
- "Interleukin5 a novel target for asthma therapy", 1(3), pp.433~453 (2001)
- "Interleukin-5 as a potential target for asthma treatment", 13(4), pp.197~205 (2000)
- "Effects of an Interleukin5 blocking monoclonal antibody on eosinophils airway hyper responsiveness and the late asthmatic response", 356, pp.2144~2148 (2000)
- "기도내 호산구성 염증에서 IL-5와 Eotaxin의 역할", 24(1), pp.127~136 (2004)
- "호산구성 기관지염과 천식의 객담내 IL5과 IL13 기도 과민성과의 연관", 25(3), pp.210~216 (2005)
- "IL-5에 의한 호산구 활성화 및 생존에 미치는 Sophoricoside의 억제능", 23(3), pp.459~466 (2003)
